Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type C D052556 1 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Sensation Disorders D012678 2 associated lipids
Ileus D045823 3 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Ovarian Diseases D010049 5 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Wang F and Fishman DA Lysophosphatidic acid and invasion. 2009 Cancer Treat. Res. pmid:19763441
Kawamori T et al. Role for sphingosine kinase 1 in colon carcinogenesis. 2009 FASEB J. pmid:18824518
Rohatagi S et al. Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator. 2009 J Clin Pharmacol pmid:18948412
Satoh Y et al. Regulation by sphingolipids of the fate of FRTL-5 cells. 2009 J. Biochem. pmid:18953023
Alford SK et al. Endothelial cell migration in human plasma is enhanced by a narrow range of added sphingosine 1-phosphate: implications for biomaterials design. 2009 J Biomed Mater Res A pmid:18286622
Hendriks-Balk MC et al. Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells. 2009 Eur. J. Pharmacol. pmid:19374869
Nincheri P et al. Sphingosine 1-phosphate induces differentiation of adipose tissue-derived mesenchymal stem cells towards smooth muscle cells. 2009 Cell. Mol. Life Sci. pmid:19337690
Schulz C et al. Hematopoietic stem and progenitor cells: their mobilization and homing to bone marrow and peripheral tissue. 2009 Immunol. Res. pmid:19340403
Sasaki H et al. pH dependence of sphingosine aggregation. 2009 Biophys. J. pmid:19348755
Straub AC et al. Arsenic requires sphingosine-1-phosphate type 1 receptors to induce angiogenic genes and endothelial cell remodeling. 2009 Am. J. Pathol. pmid:19349368
Rodríguez C et al. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin. 2009 Thromb. Haemost. pmid:19350109
Formigli L et al. Regulation of transient receptor potential canonical channel 1 (TRPC1) by sphingosine 1-phosphate in C2C12 myoblasts and its relevance for a role of mechanotransduction in skeletal muscle differentiation. 2009 J. Cell. Sci. pmid:19351713
Li Y and Yu KL [Advances in thrombin-protease-activated receptor 1-sphingosine 1-phosphate pathway during sepsis]. 2009 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:19278594
He X et al. Quantitative analysis of sphingosine-1-phosphate by HPLC after napthalene-2,3-dicarboxaldehyde (NDA) derivatization. 2009 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:19285924
Kenagy RD et al. Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. 2009 J. Vasc. Surg. pmid:19307078
Milara J et al. Sphingosine-1-phosphate increases human alveolar epithelial IL-8 secretion, proliferation and neutrophil chemotaxis. 2009 Eur. J. Pharmacol. pmid:19285497
Salinas NR et al. Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720. 2009 Pathol. Oncol. Res. pmid:19214784
Choi SK et al. Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery. 2009 Cardiovasc. Res. pmid:19218288
Huang YL et al. Tyrosine sulphation of sphingosine 1-phosphate 1 (S1P1) is required for S1P-mediated cell migration in primary cultures of human umbilical vein endothelial cells. 2009 J. Biochem. pmid:19692429
Antoon JW et al. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. 2009 J. Med. Chem. pmid:19694470
Zhao J et al. Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: role in barrier enhancement. 2009 Cell. Signal. pmid:19755153
Brindley DN and Pilquil C Lipid phosphate phosphatases and signaling. 2009 J. Lipid Res. pmid:19066402
Kennedy S et al. Targeting sphingosine-1-phosphate signalling for cardioprotection. 2009 Curr Opin Pharmacol pmid:19070545
Kirby RJ et al. Dynamic regulation of sphingosine-1-phosphate homeostasis during development of mouse metanephric kidney. 2009 Am. J. Physiol. Renal Physiol. pmid:19073640
Kawahara A et al. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. 2009 Science pmid:19074308
Lee JF et al. Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature. 2009 Am. J. Physiol. Heart Circ. Physiol. pmid:19011048
Karliner JS Sphingosine kinase regulation and cardioprotection. 2009 Cardiovasc. Res. pmid:19017750
Hashimoto T et al. Sphingosine kinase is induced in mouse 3T3-L1 cells and promotes adipogenesis. 2009 J. Lipid Res. pmid:19020339
Maeurer C et al. Sphingosine-1-phosphate induced mTOR-activation is mediated by the E3-ubiquitin ligase PAM. 2009 Cell. Signal. pmid:19000755
Ikeda H et al. Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. 2009 J. Lipid Res. pmid:18955732
Ranty ML et al. Ceramide production associated with retinal apoptosis after retinal detachment. 2009 Graefes Arch. Clin. Exp. Ophthalmol. pmid:18958490
Young N et al. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. 2009 Mol. Cancer Res. pmid:19147534
Weis N et al. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. 2009 Mol. Biol. Cell pmid:19129475
Li MH et al. S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. 2009 Cancer Lett. pmid:19131156
Gérard A et al. The Rac activator Tiam1 controls efficient T-cell trafficking and route of transendothelial migration. 2009 Blood pmid:19139083
Li X et al. Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viability. 2009 Cancer Lett. pmid:19446953
Sim-Selley LJ et al. Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS. 2009 J. Neurochem. pmid:19493165
Malchinkhuu E et al. Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid--induced migration by isoproterenol in glioma cells. 2009 Mol. Biol. Cell pmid:19864456
Monier A et al. Horizontal gene transfer of an entire metabolic pathway between a eukaryotic alga and its DNA virus. 2009 Genome Res. pmid:19451591
Morris AJ et al. Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation. 2009 Trends Cardiovasc. Med. pmid:19818950
O'Brien N et al. Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies. 2009 J. Lipid Res. pmid:19509417
Tachikawa M et al. Lysophospholipids enhance taurine release from rat retinal vascular endothelial cells under hypoosmotic stress. 2009 Microvasc. Res. pmid:19804786
Minamitani C et al. Involvement of Rho-kinase in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts. 2009 Int. J. Mol. Med. pmid:19513538
Liu X et al. Effect of sphingosine 1-phosphate on morphological and functional responses in endothelia and venules after scalding injury. 2009 Burns pmid:19520517
Okajima F et al. [Role of S1P in the lipoprotein-induced actions and their signaling mechanism]. 2009 Seikagaku pmid:19522297
Chang CL et al. S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells. 2009 Am. J. Physiol., Cell Physiol. pmid:19474291
Schulz C et al. Trafficking of murine hematopoietic stem and progenitor cells in health and vascular disease. 2009 Microcirculation pmid:19479622
Kimber I et al. Langerhans cell migration: not necessarily always at the center of the skin sensitization universe. 2009 J. Invest. Dermatol. pmid:19603050
Pyne NJ et al. New aspects of sphingosine 1-phosphate signaling in mammalian cells. 2009 Adv. Enzyme Regul. pmid:19534035
Price MM et al. Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. 2009 FASEB J. pmid:19535686
Nixon GF Sphingolipids in inflammation: pathological implications and potential therapeutic targets. 2009 Br. J. Pharmacol. pmid:19563535
Taniguchi K et al. Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. 2009 Cancer Sci. pmid:19493272
Knapp M et al. Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction. 2009 Med. Sci. Monit. pmid:19721401
Ren S et al. Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. 2009 Kidney Int. pmid:19657322
Grabski AD et al. Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19608972
Weigert A et al. Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype. 2009 Int. J. Cancer pmid:19618460
Li C et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. 2009 J. Hepatol. pmid:19398237
Guzmán-Hernández ML et al. Differential inhibitor of Gbetagamma signaling to AKT and ERK derived from phosducin-like protein: effect on sphingosine 1-phosphate-induced endothelial cell migration and in vitro angiogenesis. 2009 J. Biol. Chem. pmid:19403526
Michaud MD et al. Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19423865
Mullershausen F et al. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. 2009 Nat. Chem. Biol. pmid:19430484
Tao R et al. Cardiomyocyte S1P1 receptor-mediated extracellular signal-related kinase signaling and desensitization. 2009 J. Cardiovasc. Pharmacol. pmid:19433984
Yang G et al. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19435851
Yin H et al. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. 2009 J. Biol. Chem. pmid:19286662
Hofmann U et al. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. 2009 Cardiovasc. Res. pmid:19416991
Ader I et al. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. 2009 Cancer Res. pmid:19383898
Wetter JA et al. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation. 2009 J Biomol Screen pmid:19726785
Okada T et al. Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system. 2009 Cell. Signal. pmid:18694820
Foster DJ et al. Muscarinic receptor regulation of osmosensitive taurine transport in human SH-SY5Y neuroblastoma cells. 2009 J. Neurochem. pmid:19012745
Hla T Plugging vascular leak by sphingosine kinase from bone marrow progenitor cells. 2009 Circ. Res. pmid:19797192
Gratschev D et al. Sphingosine kinase as a regulator of calcium entry through autocrine sphingosine 1-phosphate signaling in thyroid FRTL-5 cells. 2009 Endocrinology pmid:19797403
Xiang Y et al. Discovery of novel sphingosine kinase 1 inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19800228
Espinosa Cervantes R [Sphingolipids in embryonic implantation]. 2009 Ginecol Obstet Mex pmid:19899433
Okajima F et al. Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I. 2009 Endocr. J. pmid:18753704
Brinkmann V FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. 2009 Br. J. Pharmacol. pmid:19814729
Wojciak JM et al. The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19815502
Jacobson JR Pharmacologic therapies on the horizon for acute lung injury/acute respiratory distress syndrome. 2009 J. Investig. Med. pmid:19820408
Jenne CN et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. 2009 J. Exp. Med. pmid:19808259
Long DA and Price KL Sphingosine kinase-1: a potential mediator of renal fibrosis. 2009 Kidney Int. pmid:19789541
Heo K et al. Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. 2009 BMB Rep pmid:19874715
Jongsma M et al. Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)). 2009 Br. J. Pharmacol. pmid:19309361
Bedia C et al. Synthesis of a fluorogenic analogue of sphingosine-1-phosphate and its use to determine sphingosine-1-phosphate lyase activity. 2009 Chembiochem pmid:19226506
Rodgers A et al. Sphingosine 1-phosphate regulation of extracellular signal-regulated kinase-1/2 in embryonic stem cells. 2009 Stem Cells Dev. pmid:19228106
Gellings Lowe N et al. Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts. 2009 Cardiovasc. Res. pmid:19228708
Garcia JG Concepts in microvascular endothelial barrier regulation in health and disease. 2009 Microvasc. Res. pmid:19232241
Igarashi J and Michel T Sphingosine-1-phosphate and modulation of vascular tone. 2009 Cardiovasc. Res. pmid:19233865
Sattler K and Levkau B Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. 2009 Cardiovasc. Res. pmid:19233866
Ishii M et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. 2009 Nature pmid:19204730
Zhang ZY et al. FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis. 2009 Neuropathol. Appl. Neurobiol. pmid:19207263
Gillies L et al. The sphingosine 1-phosphate receptor 5 and sphingosine kinases 1 and 2 are localised in centrosomes: possible role in regulating cell division. 2009 Cell. Signal. pmid:19211033
Sensken SC and Gräler MH [Sphingolipids and their medical impact]. 2009 Dtsch. Med. Wochenschr. pmid:19180419
Karliner JS Sphingosine kinase and sphingosine 1-phosphate in cardioprotection. 2009 J. Cardiovasc. Pharmacol. pmid:19247197
Bandhuvula P et al. Sphingosine 1-phosphate lyase enzyme assay using a BODIPY-labeled substrate. 2009 Biochem. Biophys. Res. Commun. pmid:19250638
Pasquaré SJ et al. Age-related changes in the metabolization of phosphatidic acid in rat cerebral cortex synaptosomes. 2009 Arch. Biochem. Biophys. pmid:19691145
Hagen N et al. Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons. 2009 J. Biol. Chem. pmid:19251691
Sandhu KS et al. Regional heterogeneity in expression of the sphingosine-1-phosphate pathway in the female rat lower urinary tract. 2009 Am. J. Obstet. Gynecol. pmid:19254791
Valverde O et al. GPR3 receptor, a novel actor in the emotional-like responses. 2009 PLoS ONE pmid:19259266
Chien CC et al. Activation of telomerase and cyclooxygenase-2 in PDGF and FGF inhibition of C2-ceramide-induced apoptosis. 2009 J. Cell. Physiol. pmid:18932216
Estrada R et al. Ligand-induced nuclear translocation of S1P(1) receptors mediates Cyr61 and CTGF transcription in endothelial cells. 2009 Histochem. Cell Biol. pmid:18936953
Maceyka M et al. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling. 2009 J. Lipid Res. pmid:18987387
Xu Y et al. Lipid generation and signaling in ovarian cancer. 2009 Cancer Treat. Res. pmid:19763440